Ads
related to: triamcinolone injection- Safety & Risk Factor Info
View Metabolic Syndrome Risk Info
For a Psoriasis Treatment Option.
- Safety & Prescribing Info
View Safety & Prescription Info for
a Plaque Psoriasis Treatment.
- Find Resources For HCPs
Learn About Services To Help
Patients Start And Stay On Therapy.
- Real-World Data for HCPs
Review Real-World Study Results
For a Psoriasis Treatment Option.
- Biologic MOA for PsO
Learn More About the MOA for this
Plaque Psoriasis Treatment.
- Important HCP Information
See Psoriasis Treatment Options To
Help Your Patients Find Relief.
- Safety & Risk Factor Info
Search results
Results From The WOW.Com Content Network
Triamcinolone acetonide, sold under the brand name Kenalog among others, is a synthetic corticosteroid medication used topically to treat various skin conditions, [13] to relieve the discomfort of mouth sores, and by injection into joints to treat various joint conditions.
Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. [6] It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD). [6] It can be taken in various ways including by mouth, injection into a muscle, and inhalation. [6]
Supratarsal injection is an ocular route of drug administration. It is used to administer a medication to the Tarsus of the eyelid . Supratarsal injection of corticosteroids , such as hydrocortisone , triamcinolone acetonide and dexametasone , [ 1 ] is indicated in the treatment of refractory or recalcitrant vernal keratoconjunctivitis (VKC ...
Triamcinolone hexacetonide (brand name Aristospan; also known as triamcinolone acetonide 21-tebutate) is a synthetic glucocorticoid corticosteroid. [ 3 ] [ 4 ] [ 5 ] It is on the World Health Organization's List of Essential Medicines .
Triamcinolone benetonide (brand names Alcorten, Benecorten, Tibicorten; also known as triamcinolone acetonide 21-(benzoyl-β-aminoisobutyrate) or TBI) is a synthetic glucocorticoid corticosteroid. [ 1 ] [ 2 ] [ 3 ]
The number of injections tripled to 15,000 in 2002 when triamcinolone injections were first used to treat diabetic macular oedema. [2] [3] This use continued to drive an increase to 83,000 injections in 2004. [2] In 2005 bevacizumab and ranibizumab intravitreal injections for the treatment of wet-AMD caused a rise in injections to 252,000. [2]
Ads
related to: triamcinolone injection